Control (n=6) | Predicted survival (n=7) | Predicted non-survival (n=5) | ||
---|---|---|---|---|
IL-6 (ng/mL) | Placebo | 0.1 (0.0–0.1) | 2.1 (2.0–3.5) | 12.9 (8.2–18.4) |
Esmolol | - | 1.4 (1.0–1.7) ^ | 3.0 (2.2–4.5) ^ | |
IL-10 (ng/mL) | Placebo | 0.0 (0.0–0.1) | 0.4 (0.2–0.6) | 0.7 (0.4–1.0) |
Esmolol | - | 1.4 (1.3–3.2) ^ | 1.2 (0.7–3.2) | |
Adrenaline (ng/mL) | Placebo | 5.5 (4.7–6.3) | 7.1 (5.3–15.4) | 6.2 (5.5–12.8) |
Esmolol | - | 6.4 (5.2–12.3) | 8.9 (7.0–9.3) | |
Noradrenaline (ng/mL) | Placebo | 0.5 (0.2–0.7) | 3.2 (2.9–4.8) | 3.2 (1.2–5.1) |
Esmolol | - | 2.6 (2.0–3.5) | 3.0 (1.4–5.0) |